Cargando…

International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012

BACKGROUND: Device-associated healthcare-acquired infections (DA-HAI) pose a threat to patient safety, particularly in the intensive care unit (ICU). We report the results of the International Infection Control Consortium (INICC) study conducted in Turkey from August 2003 through October 2012. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Leblebicioglu, Hakan, Erben, Nurettin, Rosenthal, Victor Daniel, Atasay, Begüm, Erbay, Ayse, Unal, Serhat, Senol, Gunes, Willke, Ayse, Özgültekin, Asu, Altin, Nilgün, Bakir, Mehmet, Oncul, Oral, Ersöz, Gülden, Ozdemir, Davut, Yalcin, Ata Nevzat, Özdemir, Halil, Yıldızdaş, Dinçer, Koksal, Iftihar, Aygun, Canan, Sirmatel, Fatma, Sener, Alper, Tuna, Nazan, Akan, Özay Arikan, Turgut, Huseyin, Demiroz, A Pekcan, Kendirli, Tanil, Alp, Emine, Uzun, Cengiz, Ulusoy, Sercan, Arman, Dilek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255447/
https://www.ncbi.nlm.nih.gov/pubmed/25403704
http://dx.doi.org/10.1186/s12941-014-0051-3
_version_ 1782347433991208960
author Leblebicioglu, Hakan
Erben, Nurettin
Rosenthal, Victor Daniel
Atasay, Begüm
Erbay, Ayse
Unal, Serhat
Senol, Gunes
Willke, Ayse
Özgültekin, Asu
Altin, Nilgün
Bakir, Mehmet
Oncul, Oral
Ersöz, Gülden
Ozdemir, Davut
Yalcin, Ata Nevzat
Özdemir, Halil
Yıldızdaş, Dinçer
Koksal, Iftihar
Aygun, Canan
Sirmatel, Fatma
Sener, Alper
Tuna, Nazan
Akan, Özay Arikan
Turgut, Huseyin
Demiroz, A Pekcan
Kendirli, Tanil
Alp, Emine
Uzun, Cengiz
Ulusoy, Sercan
Arman, Dilek
author_facet Leblebicioglu, Hakan
Erben, Nurettin
Rosenthal, Victor Daniel
Atasay, Begüm
Erbay, Ayse
Unal, Serhat
Senol, Gunes
Willke, Ayse
Özgültekin, Asu
Altin, Nilgün
Bakir, Mehmet
Oncul, Oral
Ersöz, Gülden
Ozdemir, Davut
Yalcin, Ata Nevzat
Özdemir, Halil
Yıldızdaş, Dinçer
Koksal, Iftihar
Aygun, Canan
Sirmatel, Fatma
Sener, Alper
Tuna, Nazan
Akan, Özay Arikan
Turgut, Huseyin
Demiroz, A Pekcan
Kendirli, Tanil
Alp, Emine
Uzun, Cengiz
Ulusoy, Sercan
Arman, Dilek
author_sort Leblebicioglu, Hakan
collection PubMed
description BACKGROUND: Device-associated healthcare-acquired infections (DA-HAI) pose a threat to patient safety, particularly in the intensive care unit (ICU). We report the results of the International Infection Control Consortium (INICC) study conducted in Turkey from August 2003 through October 2012. METHODS: A DA-HAI surveillance study in 63 adult, paediatric ICUs and neonatal ICUs (NICUs) from 29 hospitals, in 19 cities using the methods and definitions of the U.S. NHSN and INICC methods. RESULTS: We collected prospective data from 94,498 ICU patients for 647,316 bed days. Pooled DA-HAI rates for adult and paediatric ICUs were 11.1 central line-associated bloodstream infections (CLABSIs) per 1000 central line (CL)-days, 21.4 ventilator-associated pneumonias (VAPs) per 1000 mechanical ventilator (MV)-days and 7.5 catheter-associated urinary tract infections (CAUTIs) per 1000 urinary catheter-days. Pooled DA-HAI rates for NICUs were 30 CLABSIs per 1000 CL-days, and 15.8 VAPs per 1000 MV-days. Extra length of stay (LOS) in adult and paediatric ICUs was 19.4 for CLABSI, 8.7 for VAP and 10.1 for CAUTI. Extra LOS in NICUs was 13.1 for patients with CLABSI and 16.2 for patients with VAP. Extra crude mortality was 12% for CLABSI, 19.4% for VAP and 10.5% for CAUTI in ICUs, and 15.4% for CLABSI and 10.5% for VAP in NICUs. Pooled device use (DU) ratios for adult and paediatric ICUs were 0.54 for MV, 0.65 for CL and 0.88 for UC, and 0.12 for MV, and 0.09 for CL in NICUs. The CLABSI rate was 8.5 per 1,000 CL days in the Medical Surgical ICUs included in this study, which is higher than the INICC report rate of 4.9, and more than eight times higher than the NHSN rate of 0.9. Similarly, the VAP and CAUTI rates were higher compared with U.S. NHSN (22.3 vs. 1.1 for VAP; 7.9 vs. 1.2 for CAUTI) and with the INICC report (22.3 vs. 16.5 in VAP; 7.9 vs. 5.3 in CAUTI). CONCLUSIONS: DA-HAI rates and DU ratios in our ICUs were higher than those reported in the INICC global report and in the US NHSN report.
format Online
Article
Text
id pubmed-4255447
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42554472014-12-05 International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012 Leblebicioglu, Hakan Erben, Nurettin Rosenthal, Victor Daniel Atasay, Begüm Erbay, Ayse Unal, Serhat Senol, Gunes Willke, Ayse Özgültekin, Asu Altin, Nilgün Bakir, Mehmet Oncul, Oral Ersöz, Gülden Ozdemir, Davut Yalcin, Ata Nevzat Özdemir, Halil Yıldızdaş, Dinçer Koksal, Iftihar Aygun, Canan Sirmatel, Fatma Sener, Alper Tuna, Nazan Akan, Özay Arikan Turgut, Huseyin Demiroz, A Pekcan Kendirli, Tanil Alp, Emine Uzun, Cengiz Ulusoy, Sercan Arman, Dilek Ann Clin Microbiol Antimicrob Research BACKGROUND: Device-associated healthcare-acquired infections (DA-HAI) pose a threat to patient safety, particularly in the intensive care unit (ICU). We report the results of the International Infection Control Consortium (INICC) study conducted in Turkey from August 2003 through October 2012. METHODS: A DA-HAI surveillance study in 63 adult, paediatric ICUs and neonatal ICUs (NICUs) from 29 hospitals, in 19 cities using the methods and definitions of the U.S. NHSN and INICC methods. RESULTS: We collected prospective data from 94,498 ICU patients for 647,316 bed days. Pooled DA-HAI rates for adult and paediatric ICUs were 11.1 central line-associated bloodstream infections (CLABSIs) per 1000 central line (CL)-days, 21.4 ventilator-associated pneumonias (VAPs) per 1000 mechanical ventilator (MV)-days and 7.5 catheter-associated urinary tract infections (CAUTIs) per 1000 urinary catheter-days. Pooled DA-HAI rates for NICUs were 30 CLABSIs per 1000 CL-days, and 15.8 VAPs per 1000 MV-days. Extra length of stay (LOS) in adult and paediatric ICUs was 19.4 for CLABSI, 8.7 for VAP and 10.1 for CAUTI. Extra LOS in NICUs was 13.1 for patients with CLABSI and 16.2 for patients with VAP. Extra crude mortality was 12% for CLABSI, 19.4% for VAP and 10.5% for CAUTI in ICUs, and 15.4% for CLABSI and 10.5% for VAP in NICUs. Pooled device use (DU) ratios for adult and paediatric ICUs were 0.54 for MV, 0.65 for CL and 0.88 for UC, and 0.12 for MV, and 0.09 for CL in NICUs. The CLABSI rate was 8.5 per 1,000 CL days in the Medical Surgical ICUs included in this study, which is higher than the INICC report rate of 4.9, and more than eight times higher than the NHSN rate of 0.9. Similarly, the VAP and CAUTI rates were higher compared with U.S. NHSN (22.3 vs. 1.1 for VAP; 7.9 vs. 1.2 for CAUTI) and with the INICC report (22.3 vs. 16.5 in VAP; 7.9 vs. 5.3 in CAUTI). CONCLUSIONS: DA-HAI rates and DU ratios in our ICUs were higher than those reported in the INICC global report and in the US NHSN report. BioMed Central 2014-11-18 /pmc/articles/PMC4255447/ /pubmed/25403704 http://dx.doi.org/10.1186/s12941-014-0051-3 Text en © Leblebicioglu et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Leblebicioglu, Hakan
Erben, Nurettin
Rosenthal, Victor Daniel
Atasay, Begüm
Erbay, Ayse
Unal, Serhat
Senol, Gunes
Willke, Ayse
Özgültekin, Asu
Altin, Nilgün
Bakir, Mehmet
Oncul, Oral
Ersöz, Gülden
Ozdemir, Davut
Yalcin, Ata Nevzat
Özdemir, Halil
Yıldızdaş, Dinçer
Koksal, Iftihar
Aygun, Canan
Sirmatel, Fatma
Sener, Alper
Tuna, Nazan
Akan, Özay Arikan
Turgut, Huseyin
Demiroz, A Pekcan
Kendirli, Tanil
Alp, Emine
Uzun, Cengiz
Ulusoy, Sercan
Arman, Dilek
International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012
title International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012
title_full International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012
title_fullStr International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012
title_full_unstemmed International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012
title_short International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012
title_sort international nosocomial infection control consortium (inicc) national report on device-associated infection rates in 19 cities of turkey, data summary for 2003–2012
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255447/
https://www.ncbi.nlm.nih.gov/pubmed/25403704
http://dx.doi.org/10.1186/s12941-014-0051-3
work_keys_str_mv AT leblebiciogluhakan internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT erbennurettin internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT rosenthalvictordaniel internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT atasaybegum internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT erbayayse internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT unalserhat internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT senolgunes internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT willkeayse internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT ozgultekinasu internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT altinnilgun internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT bakirmehmet internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT onculoral internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT ersozgulden internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT ozdemirdavut internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT yalcinatanevzat internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT ozdemirhalil internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT yıldızdasdincer internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT koksaliftihar internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT ayguncanan internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT sirmatelfatma internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT seneralper internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT tunanazan internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT akanozayarikan internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT turguthuseyin internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT demirozapekcan internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT kendirlitanil internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT alpemine internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT uzuncengiz internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT ulusoysercan internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012
AT armandilek internationalnosocomialinfectioncontrolconsortiuminiccnationalreportondeviceassociatedinfectionratesin19citiesofturkeydatasummaryfor20032012